Investing Profile

Tim Shannon

VCInvestor
General Partner at Canaan Partners
canaan.com/team/tim-shannonWestport, Connecticut
Photo of Tim Shannon, General Partner at Canaan Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Canaan Partners General Partner
$250K - $20.0M
$10.0M
21
$800M
CompanyStageDateRound SizeTotal Raised
Acesion Pharma
Series BSep 2023$48M
$51M
Co-investors: Christopher de Souza (Broadview Ventures)
Aer Therapeutics
Series AApr 2023$36M
$36M
Co-investors: Rishi Gupta (OrbiMed), Christy Shaffer (Hatteras Venture Partners)
Normunity
Series AOct 2022$65M
$65M
Rallybio
Series BApr 2020$150M
Series AApr 2018$37M
$180M
Co-investors: Rob Hopfner (Pivotal bioVenture Partners)
NextCure
Series BNov 2018$93M
Series AJan 2016$67M
$160M
Co-investors: Colleen Cuffaro (Canaan Partners), David Kabakoff (HealthQuest Capital)
Arvinas
Series CApr 2018$55M
Series BOct 2015$42M
Series ASep 2013$15M
$140M
Co-investors: Stephen Squinto (OrbiMed), Kush Parmar (5am Ventures), Colleen Cuffaro (Canaan Partners), Andrew Levin (RA Capital), Jakob Loven (Nextech Invest), Martin Alexander Gershon (Endeavor Venture Funds), Liam Ratcliffe (Access Biotechnology), Daniel Wagner (Connecticut Innovations)
IDEAYA Biosciences
Series BMar 2018$94M
Series AMay 2016$46M
$140M
Co-investors: Vineeta Agarwala (Andreessen Horowitz), Thilo Schroeder (Nextech Invest)
Vivace Therapeutics
Series BJun 2017$25M
$25M